Abstract
The dietary polyphenol trans-resveratrol (3,5,4′-trihydroxy-trans-stilbene) is glucuronidated at the 3 and 4′ positions to yield two major glucuronide conjugates, resveratrol-3-O-glucuronide (R3G) and resveratrol-4′-O-glucuronide (R4′G). The major enzymes catalyzing this conjugation reaction are members of the UDP-glucuronosyl transferase (UGT) 1A family and include UGT1A1 and UGT1A9, with minor contributions by UGT1A10. The kinetics of resveratrol glucuronidation in these three UGT1A isoforms as well as in human liver and intestinal microsomes were characterized across a wide concentration range. Atypical kinetics were observed for resveratrol glucuronidation in all the protein sources studied. The Vmax estimate per total protein for both glucuronides was higher in human intestinal microsomes compared with human liver microsomes (12.2 ± 0.34 versus 7.4 ± 0.25 nmol/min/mg for R3G and 8.9 ± 0.14 versus 0.45 ± 0.01 nmol/min/mg for R4′G). The kinetic profile for formation of R3G in both human liver and intestinal microsomes fits a substrate inhibition model, whereas that for R4′G exhibited a biphasic kinetic profile in human liver microsomes and substrate inhibition in human intestinal microsomes. In recombinant human UGT supersomes, for both glucuronides, UGT1A9 exhibited higher activity than UGT1A1, whereas the lowest activity was observed with UGT1A10. The kinetic profile for R3G exhibited substrate inhibition for all three isoforms, whereas that for R4′G differed, exhibiting substrate inhibition for UGT1A1 and UGT1A10 and Hill kinetics for UGT1A9. These results suggest that in vitro kinetics of resveratrol glucuronidation at high concentrations cannot be ignored in predicting in vivo clearance upon high-dose consumption of resveratrol.
Footnotes
-
This study was partially supported by grants from the Cancer Research and Prevention Foundation (Alexandria VA) and from the Temple University Research Incentive Funds (to S.N.).
-
This work has been accepted for presentation as a poster at the 2007 Annual Meeting of the American Association of Pharmaceutical Scientists, to be held November 11 to 15 in San Diego, CA.
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.107.018788.
-
ABBREVIATIONS: resveratrol, trans-resveratrol, 3,5,4′-trihydroxy-trans-stilbene; UGT, UDP-glucuronosyl transferase; UDPGA, UDP-glucuronic acid; R3G, resveratrol 3-O glucuronide; R4′G, resveratrol 4′-O glucuronide; DMSO, dimethyl sulfoxide; HPLC, high-performance liquid chromatography; HLM, human liver microsome; TTBS, Tris-buffered saline with 0.05% Tween 20; HIM, human intestinal microsome; E-H, Eadie-Hofstee plot.
- Received September 7, 2007.
- Accepted November 6, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|